Simon Wong

1.2k total citations
24 papers, 438 citations indexed

About

Simon Wong is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Simon Wong has authored 24 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in Simon Wong's work include Pharmacogenetics and Drug Metabolism (13 papers), Receptor Mechanisms and Signaling (6 papers) and Porphyrin Metabolism and Disorders (4 papers). Simon Wong is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Receptor Mechanisms and Signaling (6 papers) and Porphyrin Metabolism and Disorders (4 papers). Simon Wong collaborates with scholars based in United States, Canada and Germany. Simon Wong's co-authors include Jeffrey W. Card, William J. Racz, Gerald S. Marks, Yingcai Wang, Jiwen Liu, George Tonn, Bradley K. Wong, Xian‐Yun Jiao, TaeWeon Lee and Hui Tian and has published in prestigious journals such as Analytical Biochemistry, Molecular Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

Simon Wong

24 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon Wong United States	13	228	118	100	77	54	24	438
Chris Black United States	12	396 1.7×	194 1.6×	110 1.1×	46 0.6×	48 0.9×	13	954
Lai Wang China	11	183 0.8×	58 0.5×	145 1.4×	119 1.5×	40 0.7×	17	464
Karen Richards United States	8	284 1.2×	107 0.9×	88 0.9×	68 0.9×	18 0.3×	13	477
Harilal Patel India	13	202 0.9×	35 0.3×	75 0.8×	72 0.9×	52 1.0×	46	512
Eugene C. Chen United States	11	225 1.0×	74 0.6×	278 2.8×	91 1.2×	27 0.5×	14	617
Viral Vyas United States	11	271 1.2×	41 0.3×	188 1.9×	72 0.9×	16 0.3×	15	459
Ola Fjellström Sweden	20	550 2.4×	60 0.5×	60 0.6×	44 0.6×	28 0.5×	40	854
Guiqing Liang United States	11	171 0.8×	58 0.5×	55 0.6×	122 1.6×	16 0.3×	21	484
Daniel C. Kemp United States	9	179 0.8×	133 1.1×	124 1.2×	19 0.2×	43 0.8×	11	488
Michael W. Lago United States	10	209 0.9×	34 0.3×	93 0.9×	38 0.5×	29 0.5×	13	538

Countries citing papers authored by Simon Wong

Since Specialization

Citations

This map shows the geographic impact of Simon Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Wong more than expected).

Fields of papers citing papers by Simon Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Wong. The network helps show where Simon Wong may publish in the future.

Co-authorship network of co-authors of Simon Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Wong. A scholar is included among the top collaborators of Simon Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Wong. Simon Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wong, Simon, Diane Ramsden, Shannon Dallas, et al.. (2020). Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment. Drug Metabolism and Disposition. 49(1). 94–110. 17 indexed citations

Zhang, Donglu, et al.. (2020). NADPH-Independent Inactivation of CYP2B6 and NADPH-Dependent Inactivation of CYP3A4/5 by PBD: Potential Implication for Assessing Covalent Modulators for Time-Dependent Inhibition. Drug Metabolism and Disposition. 48(8). 655–661. 10 indexed citations

Brown, Sean P., Paul J. Dransfield, Marc Vimolratana, et al.. (2018). Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman Primates. ACS Medicinal Chemistry Letters. 9(7). 757–760. 12 indexed citations

Wang, Jing, Ryan Takahashi, Kevin DeMent, et al.. (2018). Development of a mass spectrometry-based tryptophan 2, 3-dioxygenase assay using liver cytosol from multiple species. Analytical Biochemistry. 556. 85–90. 3 indexed citations

Wong, Simon, et al.. (2016). Single concentration loss of activity assay provides an improved assessment of drug–drug interaction risk compared to IC50-shift. Xenobiotica. 46(11). 953–966. 5 indexed citations

Ma, Zhihua, Daniel C.-H. Lin, Rajiv Sharma, et al.. (2015). Discovery of the imidazole-derived GPR40 agonist AM-3189. Bioorganic & Medicinal Chemistry Letters. 26(1). 15–20. 16 indexed citations

Bui, Minna, Xiaolin Hao, Youngsook Shin, et al.. (2015). Synthesis and SAR study of potent and selective PI3Kδ inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(5). 1104–1109. 18 indexed citations

Johnson, Michael G., Jim Liu, An‐Rong Li, et al.. (2014). Solving time-dependent CYP3A4 inhibition for a series of indole-phenylacetic acid dual antagonists of the PGD2 receptors CRTH2 and DP. Bioorganic & Medicinal Chemistry Letters. 24(13). 2877–2880. 1 indexed citations

Liu, Jiwen, Yingcai Wang, Zhihua Ma, et al.. (2014). Optimization of GPR40 Agonists for Type 2 Diabetes. ACS Medicinal Chemistry Letters. 5(5). 517–521. 37 indexed citations

10.

Henne, Kirk R., Thuy Tran, Brooke M. VandenBrink, et al.. (2012). Sequential Metabolism of AMG 487, a Novel CXCR3 Antagonist, Results in Formation of Quinone Reactive Metabolites That Covalently Modify CYP3A4 Cys239 and Cause Time-Dependent Inhibition of the Enzyme. Drug Metabolism and Disposition. 40(7). 1429–1440. 31 indexed citations

11.

Wong, Simon. (2011). Prediction of Drug-Drug Interactions Arising From Mechanism-Based Inactivation: Key Input Parameters and Impact on Risk Assessment. Current Drug Metabolism. 12(9). 871–890. 6 indexed citations

12.

Wong, Simon, Peter W. Fan, Raju Subramanian, et al.. (2010). Bioactivation of a Novel 2-Methylindole-Containing Dual Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type-2 Cells/d-Prostanoid Receptor Antagonist Leads to Mechanism-Based CYP3A Inactivation: Glutathione Adduct Characterization and Prediction of In Vivo Drug-Drug Interaction. Drug Metabolism and Disposition. 38(5). 841–850. 9 indexed citations

13.

Wang, Yingcai, Xian‐Yun Jiao, Frank Kayser, et al.. (2009). The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 20(2). 493–498. 83 indexed citations

14.

Méthot, Nathalie, Daniel Guay, Joel Rubin, et al.. (2008). In Vivo Inhibition of Serine Protease Processing Requires a High Fractional Inhibition of Cathepsin C. Molecular Pharmacology. 73(6). 1857–1865. 46 indexed citations

15.

Tonn, George, Simon Wong, Sylvia Wong, et al.. (2008). An Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d ]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple Dosing. Drug Metabolism and Disposition. 37(3). 502–513. 25 indexed citations

16.

Sweeny, David J., Juthamas Sukbuntherng, Qingling Zhang, et al.. (2005). Distribution, metabolism, and excretion of the anti-angiogenic compound SU5416. Toxicology in Vitro. 20(2). 154–162. 31 indexed citations

17.

Wong, Simon, Jeffrey W. Card, & William J. Racz. (2000). The role of mitochondrial injury in bromobenzene and furosemide induced hepatotoxicity. Toxicology Letters. 116(3). 171–181. 46 indexed citations

18.

Wong, Simon, et al.. (2000). Use of recombinant human ferrochelatase as a sensitive bioassay for N-alkylprotoporphyrin IX formed after interaction of porphyrinogenic xenobiotics with rat liver microsomes. Canadian Journal of Physiology and Pharmacology. 78(7). 578–581. 3 indexed citations

19.

Wong, Simon & Gerald S. Marks. (1999). Formation of N-alkylprotoporphyrin IX after interaction of porphyrinogenic xenobiotics with rat liver microsomes. Journal of Pharmacological and Toxicological Methods. 42(3). 107–113. 7 indexed citations

20.

Wong, Simon, Edward Lin, & Gerald S. Marks. (1999). Cytochrome CYP Sources of N-Alkylprotoporphyrin IX after Administration of Porphyrinogenic Xenobiotics to Rats. Drug Metabolism and Disposition. 27(9). 960–965. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact